Literature DB >> 25311807

Coinfection with Streptococcus pneumoniae negatively modulates the size and composition of the ongoing influenza-specific CD8⁺ T cell response.

Lance K Blevins1, John T Wren1, Beth C Holbrook1, Sarah L Hayward1, W Edward Swords1, Griffith D Parks1, Martha A Alexander-Miller2.   

Abstract

Infection with influenza A virus can lead to increased susceptibility to subsequent bacterial infection, often with Streptococcus pneumoniae. Given the substantial modification of the lung environment that occurs following pathogen infection, there is significant potential for modulation of immune responses. In this study, we show that infection of mice with influenza virus, followed by the noninvasive EF3030 strain of Streptococcus pneumoniae, leads to a significant decrease in the virus-specific CD8(+) T cell response in the lung. Adoptive-transfer studies suggest that this reduction contributes to disease in coinfected animals. The reduced number of lung effector cells in coinfected animals was associated with increased death, as well as a reduction in cytokine production in surviving cells. Further, cells that retained the ability to produce IFN-γ exhibited a decreased potential for coproduction of TNF-α. Reduced cytokine production was directly correlated with a decrease in the level of mRNA. Negative regulation of cells in the mediastinal lymph node was minimal compared with that present in the lung, supporting a model of selective regulation in the tissue harboring high pathogen burden. These results show that entry of a coinfecting pathogen can have profound immunoregulatory effects on an ongoing immune response. Together, these findings reveal a novel dynamic interplay between concurrently infecting pathogens and the adaptive immune system.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25311807      PMCID: PMC4265766          DOI: 10.4049/jimmunol.1400529

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

Review 1.  CD8+ T cell effector mechanisms in resistance to infection.

Authors:  J T Harty; A R Tvinnereim; D W White
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Interleukin-10 impairs host defense in murine pneumococcal pneumonia.

Authors:  T van der Poll; A Marchant; C V Keogh; M Goldman; S F Lowry
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

3.  Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection.

Authors:  Lynnelle A McNamee; Allen G Harmsen
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

4.  In vivo evidence that caspase-3 is required for Fas-mediated apoptosis of hepatocytes.

Authors:  M Woo; A Hakem; A J Elia; R Hakem; G S Duncan; B J Patterson; T W Mak
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

Review 5.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

6.  Pneumococcal components induce regulatory T cells that attenuate the development of allergic airways disease by deviating and suppressing the immune response to allergen.

Authors:  Alison N Thorburn; Alexandra C Brown; Prema M Nair; Nina Chevalier; Paul S Foster; Peter G Gibson; Philip M Hansbro
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

7.  Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.

Authors:  Jonathan A McCullers; Jerold E Rehg
Journal:  J Infect Dis       Date:  2002-07-10       Impact factor: 5.226

8.  Sepsis-induced human lymphocyte apoptosis and cytokine production in "humanized" mice.

Authors:  Jacqueline Unsinger; Jacquelyn S McDonough; Leonard D Shultz; Thomas A Ferguson; Richard S Hotchkiss
Journal:  J Leukoc Biol       Date:  2009-04-15       Impact factor: 4.962

9.  Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae.

Authors:  Lynnelle A Pittet; Luanne Hall-Stoodley; Melanie R Rutkowski; Allen G Harmsen
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-11       Impact factor: 6.914

10.  Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae.

Authors:  Amber M Smith; Frederick R Adler; Ruy M Ribeiro; Ryan N Gutenkunst; Julie L McAuley; Jonathan A McCullers; Alan S Perelson
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823

View more
  22 in total

1.  Viral Coinfection Replaces Effects of Suilysin on Streptococcus suis Adherence to and Invasion of Respiratory Epithelial Cells Grown under Air-Liquid Interface Conditions.

Authors:  Georg Herrler; Nai-Huei Wu; Peter Valentin-Weigand; Fandan Meng; Jie Tong; Désirée Vötsch; Ju-Yi Peng; Xuehui Cai; Maren Willenborg
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

2.  Why is coinfection with influenza virus and bacteria so difficult to control?

Authors:  Linda S Cauley; Anthony T Vella
Journal:  Discov Med       Date:  2015-01       Impact factor: 2.970

Review 3.  The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.

Authors:  Amber M Smith; Victor C Huber
Journal:  Viral Immunol       Date:  2017-11-17       Impact factor: 2.257

4.  Pneumococcal Neuraminidase A (NanA) Promotes Biofilm Formation and Synergizes with Influenza A Virus in Nasal Colonization and Middle Ear Infection.

Authors:  John T Wren; Lance K Blevins; Bing Pang; Ankita Basu Roy; Melissa B Oliver; Jennifer L Reimche; Jessie E Wozniak; Martha A Alexander-Miller; W Edward Swords
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

5.  Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation.

Authors:  Niharika Sharma-Chawla; Vicky Sender; Olivia Kershaw; Achim D Gruber; Julia Volckmar; Birgitta Henriques-Normark; Sabine Stegemann-Koniszewski; Dunja Bruder
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

6.  Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2.

Authors:  Amanda P Smith; Evan P Williams; Taylor R Plunkett; Muneeswaran Selvaraj; Lindey C Lane; Lillian Zalduondo; Yi Xue; Peter Vogel; Rudragouda Channappanavar; Colleen B Jonsson; Amber M Smith
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

7.  Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia.

Authors:  Guillaume Voiriot; Benoit Visseaux; Johana Cohen; Liem Binh Luong Nguyen; Mathilde Neuville; Caroline Morbieu; Charles Burdet; Aguila Radjou; François-Xavier Lescure; Roland Smonig; Laurence Armand-Lefèvre; Bruno Mourvillier; Yazdan Yazdanpanah; Jean-Francois Soubirou; Stephane Ruckly; Nadhira Houhou-Fidouh; Jean-François Timsit
Journal:  Crit Care       Date:  2016-10-25       Impact factor: 9.097

Review 8.  Altered Signal Transduction in the Immune Response to Influenza Virus and S. pneumoniae or S. aureus Co-Infections.

Authors:  Janine J Wilden; Jasmin C Jacob; Christina Ehrhardt; Stephan Ludwig; Yvonne Boergeling
Journal:  Int J Mol Sci       Date:  2021-05-22       Impact factor: 5.923

9.  Exposure to common respiratory bacteria alters the airway epithelial response to subsequent viral infection.

Authors:  Carla Bellinghausen; Fahad Gulraiz; Alexandra C A Heinzmann; Mieke A Dentener; Paul H M Savelkoul; Emiel F Wouters; Gernot G Rohde; Frank R Stassen
Journal:  Respir Res       Date:  2016-06-03

10.  Phytochemical Screening and in-vitro Evaluation of Antibacterial Activities of Echinops amplexicaulis, Ruta chalepensis and Salix subserrata Against Selected Pathogenic Bacterial Strains in West Shewa Zone, Ethiopia.

Authors:  Lencho Megersa Marami; Getachew Mulatu Dilba; Dagmawit Atalel Babele; Edilu Jorga Sarba; Askale Gizaw; Wakuma Mitiku Bune; Morka Dandecha Bayu; Petros Admasu; Abraham Mekbeb; Miressa Tadesse; Kebede Abdisa; Dejene Bayisa
Journal:  J Exp Pharmacol       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.